A Shropshire pensioner who has been paying £3,000 per month for life saving cancer treatment that is free of charge on the NHS in Scotland will now receive his treatment free of charge from his Primary Care Trust (PCT).
John Green from Bridgnorth has been paying for Sorafenib Nexaval out of his own pocket because the National Institute for Clinical Excellence (National = England, of course, not the UK) hasn't approved the drug meaning that PCTs in England don't have to provide the drug when it's needed. In Scotland, the drug is available on free on the NHS because the Scottish government has an £11.3bn subsidy from the English taxpayer to spend on whatever they want.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment